Organogenesis Holdings Dividends

ORGO Stock  USD 3.84  0.01  0.26%   
As of the 11th of February 2026, Dividend Paid And Capex Coverage Ratio is likely to grow to 1.13, while Dividends Paid is likely to drop about 1.5 M. Organogenesis Holdings' past performance could be the main factor of why investors trade Organogenesis Holdings stock today. Investors should clearly understand every aspect of the Organogenesis Holdings dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Organogenesis Holdings' dividend schedule and payout information. Organogenesis Holdings dividends can also provide a clue to the current valuation of Organogenesis Holdings.
Last ReportedProjected for Next Year
Dividends Paid1.6 M1.5 M
Dividend Payout Ratio 1.88  1.67 
Dividend Paid And Capex Coverage Ratio 1.08  1.13 
One of the primary advantages of investing in dividend-paying companies such as Organogenesis Holdings is that dividends usually grow steadily over time. As a result, well-established companies that pay dividends typically increase their dividend payouts yearly, which many long-term traders find attractive.
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Organogenesis Holdings must own a stock before its ex-dividend date to receive its next dividend.

Organogenesis Holdings Dividends Paid Over Time

Today, most investors in Organogenesis Holdings Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Organogenesis Holdings' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Organogenesis Holdings dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period.
   Dividends Paid   
       Timeline  

Organogenesis Holdings Historical Dividend Yield Growth

A solid dividend growth pattern of Organogenesis Holdings could indicate future dividend growth is likely, which can signal long-term profitability for Organogenesis Holdings. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period.
Dividend Yield is Organogenesis Holdings dividend as a percentage of Organogenesis Holdings stock price. Organogenesis Holdings dividend yield is a measure of Organogenesis Holdings stock productivity, which can be interpreted as interest rate earned on an Organogenesis Holdings investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.
   Dividend Yield   
       Timeline  
Will Biotechnology sector continue expanding? Could Organogenesis diversify its offerings? Factors like these will boost the valuation of Organogenesis Holdings. Anticipated expansion of Organogenesis directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Organogenesis Holdings data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
0.222
Earnings Share
(0.08)
Revenue Per Share
3.651
Quarterly Revenue Growth
0.31
Return On Assets
0.0018
Investors evaluate Organogenesis Holdings using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Organogenesis Holdings' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Organogenesis Holdings' market price to deviate significantly from intrinsic value.
It's important to distinguish between Organogenesis Holdings' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Organogenesis Holdings should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Organogenesis Holdings' market price signifies the transaction level at which participants voluntarily complete trades.

Compare Dividends Across Peers

Specify up to 10 symbols: